Lattice Capital Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,050
Closed -$33.1K 23
2023
Q4
$33.1K Hold
15,050
﹤0.01% 23
2023
Q3
$37K Hold
15,050
﹤0.01% 31
2023
Q2
$118K Hold
15,050
0.02% 37
2023
Q1
$99K Hold
15,050
0.01% 55
2022
Q4
$87.6K Hold
15,050
0.01% 49
2022
Q3
$77K Hold
15,050
0.12% 56
2022
Q2
$85K Hold
15,050
0.01% 56
2022
Q1
$129K Hold
15,050
0.18% 67
2021
Q4
$144K Buy
+15,050
New +$175K 0.01% 78

Other funds holding MESO

Lattice Capital Management's MESO Position: Q1 2024 in Review

Lattice Capital Management sold out of Mesoblast (MESO) in Q1 2024, closing a stake of 15,050 shares — an estimated $33.1K sold.

Lattice Capital Management first reported a position in MESO in Q4 2021 and held it in 9 quarters. The position peaked at $144K in Q4 2021. 26 funds tracked by Wall St. Rank hold MESO as of Q1 2024.

  • Lattice Capital Management reported no remaining Mesoblast position as of Q1 2024 after selling out during the quarter.
  • Lattice Capital Management sold 15,050 Mesoblast shares in Q1 2024, an estimated $33.1K.
  • Lattice Capital Management first reported a position in Mesoblast in Q4 2021 and held it in 9 quarters.
  • Lattice Capital Management's Mesoblast position peaked at $144K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Mesoblast as of Q1 2024.

Based on Lattice Capital Management's 13F filing for Q1 2024, filed 24 Apr 2024.